Eli Lilly Enters the Obesity Battle: New Pill Poised to Challenge Novo Nordisk’s Oral Wegovy, Shaking Up the Weight Loss Market and Investor Landscape

Eli Lilly's obesity pill will rival Novo Nordisk's oral Wegovy drug

Eli Lilly’s Obesity Pill: Underwhelming Trial Data but a Potential Game-Changer in the Weight Loss Market Eli Lilly’s recent trial results for its obesity pill, orforglipron, sent its stock tumbling 13% initially, reflecting Wall Street’s … Read more

PLTR Stock vs. Ethereum: Navigating the Battle Between Tech Stocks and Crypto for Your Investment Portfolio

PLTR Stock or the ETH Crypto?

Ethereum vs. Palantir: Which Heavyweight Investment Should You Bet On Now? In the ever-evolving world of finance, two titans are capturing investor attention in unique ways: Ethereum (ETHUSD), the powerhouse cryptocurrency, and Palantir Technologies (PLTR), … Read more

US Tightens Grip on Chinese Transshipments: A New Front in the Escalating US-China Trade Battle with High Stakes for Global Markets

US-China Proxy Trade War Brews as US Cracks Down on Chinese Transshipments

China’s Export Rerouting Surge: What Investors Must Know About Southeast Asia’s Emerging Trade Dynamics In May, a striking $3.4 billion of China’s exports were rerouted through Vietnam—a hefty 30% year-over-year increase. Meanwhile, Indonesia also saw … Read more